Cargando…
Behavioral and antioxidant activity of a tosylbenz[g]indolamine derivative. A proposed better profile for a potential antipsychotic agent
BACKGROUND: Tardive dyskinesia (TD) is a major limitation of older antipsychotics. Newer antipsychotics have various other side effects such as weight gain, hyperglycemia, etc. In a previous study we have shown that an indolamine molecule expresses a moderate binding affinity at the dopamine D(2 )an...
Autores principales: | Zika, Chara A, Nicolaou, Ioannis, Gavalas, Antonis, Rekatas, George V, Tani, Ekaterini, Demopoulos, Vassilis J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC320490/ https://www.ncbi.nlm.nih.gov/pubmed/14711381 http://dx.doi.org/10.1186/1475-2832-3-1 |
Ejemplares similares
-
Melatonin: A Novel Indolamine in Oral Health and Disease
por: Chava, V. K., et al.
Publicado: (2012) -
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
por: Geitona, Maria, et al.
Publicado: (2008) -
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
por: Kirino, Eiji
Publicado: (2017) -
Pharmacy switch of antipsychotic medications: patient’s perspective
por: Murawiec, Slawomir, et al.
Publicado: (2015) -
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
por: Wijesundera, Hiranya, et al.
Publicado: (2014)